All systems operational
For Researchers For Publishers Login Register
Home Publications Egyptian Rheumatologist
Q3 2026

Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease

Nada M. Gamal · Eman R. Badawy · Dalia Tohamy · Esraa A. Talaat
10.1016/j.ejr.2026.01.003 393 Views 0 Citations
0
Citations
393
Views
Abstract not available for this publication.
Cite this Article (APA)
Nada, M. G., Eman, R. B., Dalia, T., Esraa, A. T. (2026). Clinical relevance of plasma soluble urokinase plasminogen activator receptor (suPAR) in Behçet’s disease. Egyptian Rheumatologist. https://doi.org/10.1016/j.ejr.2026.01.003
Related Papers
Spirulina as a promising agent in rheumatoid arthritis with no observed hepatic injury
Noha A. Fadel; Maha M. Aziz; Ghada M. Shafey; Rasha R. Rashed; Heba A. Gheita · 2024
7
cites
388
A single-center experience: Enteropathic arthritis in inflammatory bowel diseases
Barış Çabuk; Dilara Bulut Gökten; Tevfik Solakoğlu; Rafet Mete; Nurten Türkel Kü · 2024
6
cites
387
Risk of mortality among people with rheumatoid arthritis and depression
Srikanta Banerjee; Jagdish Khubchandani; Latrice Noonan; Kavita Batra; Ayana Pai · 2024
6
cites
390
Effect of first week-intermittent fasting during Ramadan on the severity of neuropsychiatric symptom…
Mona Hussein; Wael Fathy; Mohamed Abdelghaffar; Mohamed T. Hegazy; Doaa A. Teleb · 2024
5
cites
389
Access
View Full Text via DOI
Published in
ISSN 1110-1164
Quartile Q3
AMS Score 78
Field Medicine & Health Sciences
Publisher Elsevier / Egyptian Society for Rhe
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 27 Jul 2026